Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MRKR Marker Therapeutics

Watchlist
0.321
+0.014+4.56%
Close 11/25 13:00 ET
0.326
+0.004+1.34%
Post Mkt Price 11/25 16:13 ET
High
0.326
Open
0.297
Turnover
14.98K
Low
0.290
Pre Close
0.307
Volume
48.67K
Market Cap
26.85M
P/E(TTM)
Loss
52wk High
1.260
Shares
83.60M
P/E(Static)
Loss
52wk Low
0.250
Float Cap
19.20M
Bid/Ask %
93.33%
Historical High
244.800
Shs Float
59.78M
Volume Ratio
0.21
Historical Low
0.074
Dividend TTM
--
Div Yield TTM
--
P/B
1.19
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.08%
Amplitude
11.82%
Avg Price
0.307
Lot Size
1
Float Cap
19.20M
Bid/Ask %
93.33%
Historical High
244.800
Shs Float
59.78M
Volume Ratio
0.21
Historical Low
0.074
Dividend TTM
--
P/B
1.19
Dividend LFY
--
Turnover Ratio
0.08%
Amplitude
11.82%
Avg Price
0.307
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEO: Mr. Peter L. Hoang
Market: NASDAQ
Listing Date: 11/07/2016
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist